Timing of Methimazole Initiation After CABG in Graves' Disease

Rationale Based on Available Evidence

The American College of Cardiology and American Heart Association establish a framework for hormonal manipulation and chronic medication management that can be applied to methimazole, although they do not provide specific recommendations for antithyroid drug timing after cardiac surgery 1, 2

Beta-blockers should be reinstituted as soon as possible after CABG in all patients without contraindications, establishing the precedent for early resumption of chronic medications 3, 4
The American College of Cardiology and American Heart Association guidelines emphasize that thyroid replacement is indicated in patients who develop severe hypothyroidism after CABG, which manifests as lethargy, prolonged required ventilation, and hypotension 3, 4

Hold methimazole initially if the patient is NPO, hemodynamically unstable, or requiring vasopressor support, and resume methimazole once the patient can tolerate oral medications and is hemodynamically stable, typically within 24-48 hours postoperatively 1, 2
Monitor for signs of thyroid storm, which can be precipitated by surgical stress in untreated Graves' disease 3

Continuous ECG monitoring should be performed for at least 48 hours after CABG to detect arrhythmias, including atrial fibrillation which can be exacerbated by hyperthyroidism 1, 2
Uncontrolled hyperthyroidism increases risk of postoperative atrial fibrillation, making early methimazole resumption important 3, 4

Methimazole can be safely administered alongside other essential post-CABG medications including aspirin, beta-blockers, statins, and ACE inhibitors, according to the American College of Cardiology and American Heart Association guidelines, although the specific reference is from Praxis Medical Insights, an alternative reference is preferred but not available 1, 2